mRNA combination vaccines for respiratory infections: the developer’s view

“...combining targets by symptoms allows for a more integrated approach to seasonal vaccination campaigns...”

Charlotte Barker, Commissioning Editor, Vaccine Insights, catches up with Francesca Ceddia, Chief Medical Affairs Officer, Moderna, to learn more about the company’s efforts to develop mRNA-based combination vaccines against COVID-19, RSV, and influenza.

Please enter your email to access content Read now